G. Sole, A. D. De Bolla, D. Arkell
Jul 31, 1982
British Medical Journal (Clinical research ed.)
bed. The number of dressing changes required was considerably reduced because the exudate was able to be aspirated from around his rather large lesions using an ordinary hypodermic needle and syringe, the small puncture hole being "repaired" with a small square of OpSite. The lesions could be easily examined through the transparent dressings, which required changing at approximately 10-day intervals. It is unfortunate that this product is not currently available on the drug tariff despite its ability to produce savings in terms of doctor and nurse time and the number of dressings required. In this particular case because it reduced the odour associated with the skin metastases the patient's admission to hospital was certainly avoided. I feel that the DHSS should therefore revise its drug tariff products and allow the community health care personnel the benefits of the same products used successfully in hospitals.